Open-label Study to Evaluate the Safety and Efficacy

Project: Research project

Project Details

Description

Open-label Study to Evaluate the Safety and Efficacy of the Combination of Ombitasvir, Paritaprevir/r +/- Dasabuvir with Ribavirin (RBV) in Adult Patients with GT1 or GT4 Chronic HCV Infection and Response to Prior Treatment of Early Stage Hepatocellular
StatusFinished
Effective start/end date7/1/1510/31/16

Funding

  • ABBVIE INC.

Fingerprint Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.